ContraFect Corporation announced that in connection with the Restructuring Plan, on November 15, 2023, Roger J. Pomerantz resigned as the Chief Executive Officer of the company. Dr. Pomerantz will remain a member of the Board of Directors of the Company. In connection with the Restructuring Plan, the Board appointed Michael Messinger as the Chief Executive Officer of the Company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0117 USD | 0.00% | -33.14% | -61.00% |
03/05 | North American Morning Briefing : Apple, Amgen -2- | DJ |
26/04 | North American Morning Briefing : Tech Still in -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
-61.00% | 125K | |
+24.75% | 46.71B | |
+48.83% | 41.8B | |
-1.06% | 41.52B | |
-5.86% | 29.55B | |
+10.24% | 25.78B | |
-20.81% | 19.26B | |
+1.74% | 12.14B | |
-3.34% | 12.08B | |
+27.42% | 11.98B |
- Stock Market
- Equities
- CFRXQ Stock
- News ContraFect Corporation
- ContraFect Corporation Announces Chief Executive Officer Changes